⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Oral Protein and Peptides Market to Hit Valuation of US$ 47.33 Billion By 2035 | Astute Analytica
globenewswire.com
VKTX
LLY
NVO
MRK
FSK
TSN
KDP
PEP
MNDO
THG
ENTX
RANI
Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs
globenewswire.com
NVO
LLY
Strive Compounding Pharmacy Files Landmark Antitrust Lawsuit Against Eli Lilly and Novo Nordisk
prnewswire.com
LLY
NVO
Peptide Therapeutics Market Report 2025-2035: Industry to Experience Robust Growth with a CAGR of 6.8% Through 2035 - Subcutaneous Route to Command Over 65% Share - ResearchAndMarkets.com
businesswire.com
APLS
BLRX
LLY
NTRA
NVO
PLTK
ZBRA
TMates Review 2026: GLP-1 Telehealth, Pricing & Safety
accessnewswire.com
NVO
LLY
Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer
prnewswire.com
NVO
Biomedical and ICT Convergence Market Research Report 2025-2030: Outlook for Various Biomedical Products, Services, and Solutions Poised to Benefit from Various IT and Telecom Technologies - ResearchAndMarkets.com
businesswire.com
ABT
AMGN
ADI
AZN
BIIB
BIO
XRAY
GEHC
GILD
HON
JNJ
MD
MRK
NVDA
NOVT
NVO
NXPI
PFE
SMCI
SOXX
TE
TXN
TMO
WMT
ZBH
Wegovy Pill vs Wegovy Shot: Oral vs Injectable Semaglutide Differences — 2026 FDA Launch Analysis via Ro.co
globenewswire.com
NVO
Wegovy Pill Legitimacy Examined: 2026 Consumer Analysis Investigates Ro's Oral GLP-1 Access Pathway and No-Insurance Cash-Pay Options
globenewswire.com
NVO
Adimab Reports Strong Partnering Year for 2025
prnewswire.com
ALNY
NVO
MRK
LLY
REGN
VRTX
AZN
GSK
BIIB
SCHR
ALEC